Opinion

Sources suggest that Aon has been proactive in weighing acquisitions since Q4, with a US mid-market platform the obvious gap.

The reforms are working for claims filed after December 2022, but attorneys are still litigating claims filed prior to the legislation.

For some time now, property has been doing the heavy lifting around growth and rate rises in E&S.

The loss threats come as the space is going through a softening cycle, with 2%-2.5% rates and a few sources noting cases of 1.7%-1.8%.

Its confederation of insurance subsidiaries will have to operate with fewer strategic advantages than they do today.

AM Best’s decision to remove second-largest front Clear Blue from under review is a small positive development for the fronting sector, but caution is still needed.

Insurers should reserve as conservatively as possible, maximize their product set, and decide if they are buyers or sellers.

Sources agree that there are others that could follow a similar playbook, but there are three key considerations to keep in mind when pursuing a strategic-on-InsurTech transaction.

Trading at just 0.6x book, the firm is a cheap option for an insurer which is looking to enter E&S, or is underweight in the sector.

The broker has not been acquisitive since the deal to create the group in 2015, and has divested a number of its units in that time.

The low multiple shapes the decision set of the management team, negatively impacts staff, and creates potential opportunities for rivals.

APCIA's annual meeting last year took place during the post-Hurricane Ian stand-off, but despite the greater calm and certainty surrounding the run-up to this year’s January 1 renewal, there are several key themes to debate at the event.